In this handout provided by Stanford University News Service, Nobel Laureate Andrew Fire and Phil Pizzo, dean of the school of Medicine, attend a...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Nobel Laureate Andrew Fire attends a press conference after the announcement of the...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Nobel Laureate Andrew Fire attends a press conference after the announcement of the...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Stanford President John Hennessy, Nobel Laureate Andrew Fire and Phil Pizzo, dean of...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Stanford President John Hennessy, Nobel Laureate Andrew Fire and Phil Pizzo, dean of...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Stanford President John Hennessy and Nobel Laureate Andrew Fire attend a press...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Stanford President John Hennessy and Nobel Laureate Andrew Fire attend a press...Nobel Prize Awarded To Two Americans
In this handout provided by Stanford University News Service, Nobel Prize winner Andrew Fire is seen in this undated photo. The Nobel Assembly at...Nobel Prize Awarded To Two Americans
City Therapeutics Inc. Signage during the company's initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, during the company's initial public offering at the Nasdaq MarketSite in New...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
Guests during the City Therapeutics Inc. Initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Guests during the City Therapeutics Inc. Initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, during the company's initial public offering at the Nasdaq MarketSite in New...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, during the company's initial public offering at the Nasdaq MarketSite in New...City Therapeutics IPO At The Nasdaq MarketSite
Pedestrians outside the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of RNAi-based...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
Dow Jones and S&P 500 Index signage during the City Therapeutics Inc. Initial public offering at the Nasdaq MarketSite in New York, US, on Friday,...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
City Therapeutics Inc. Signage during the company's initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Guests during the City Therapeutics Inc. Initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Pedestrians carry umbrellas through Times Square in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, during the company's initial public offering at the Nasdaq MarketSite in New...City Therapeutics IPO At The Nasdaq MarketSite
City Therapeutics Inc. Signage during the company's initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Guests during the City Therapeutics Inc. Initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Pedestrians carry umbrellas through Times Square in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
Pedestrians carry umbrellas through Times Square in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
New York Police Department officers outside the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
City Therapeutics Inc. Signage during the company's initial public offering at the Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, during the company's initial public offering at the Nasdaq MarketSite in New...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
The Nasdaq MarketSite in New York, US, on Friday, Oct. 16, 2026. City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., center, rings the opening bell during the company's initial public offering at the...City Therapeutics IPO At The Nasdaq MarketSite
Andy Orth, chief executive officer of City Therapeutics Inc., during the company's initial public offering at the Nasdaq MarketSite in New York, US,...City Therapeutics IPO At The Nasdaq MarketSite
argonaute protein and microrna, illustration - rnai stock illustrationsArgonaute protein and microRNA, illustrationRNA
dicer bound to microrna precursor, illustration - rnai stock illustrationsDicer bound to microRNA precursor, illustrationEnzyme, Molecule, Molecular Structure
dicer bound to microrna precursor, illustration - rnai stock illustrationsDicer bound to microRNA precursor, illustrationRNA, Molecule, Three Dimensional
exportin-5 microrna complex, illustration - rnai stock illustrationsExportin-5 microRNA complex, illustrationmicroRNA
exportin-5 microrna complex, illustration - rnai stock illustrationsExportin-5 microRNA complex, illustration
let7 microrna precursor molecules, illustration - rnai stock illustrationsLet7 microRNA precursor molecules, illustration
let7 microrna and precursor molecule, illustration - rnai stock illustrationsLet7 microRNA and precursor molecule, illustrationmicroRNA
let7 microrna precursor molecules, illustration - rnai stock illustrationsLet7 microRNA precursor molecules, illustrationRNA
microrna molecules, illustration - rnai stock illustrationsMicroRNA molecules, illustrationmicroRNA, RNA, Nobel Prize
Rna Interference, Gene Expression, Silencing, In The Framework Of The Development Of New Therapies.Rna InterferenceFacial Expression, DNA
